Increased HO‐1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21-Reference-Cited by-同舟云学术

Increased HO‐1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21

Published:2013-12-02 Issue:3 Volume:22 Page:705-712
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Hinds Terry D.,Sodhi Komal¹,Meadows Charles¹,Fedorova Larisa,Puri Nitin,Kim Dong Hyun¹,Peterson Stephen J.²,Shapiro Joseph¹,Abraham Nader G.¹³,Kappas Attallah³

Affiliation:

1. Department of MedicineJoan C. Edwards School of Medicine, Marshall UniversityHuntington West Virginia USA

2. Department of MedicineNew York Methodist‐Weill Cornell Medical CollegeNew York New York USA

3. Laboratory of Pharmacology The Rockefeller UniversityNew York New York USA

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.20559

Reference39 articles.

1. Reduced hepatic glycogen stores in patients with liver cirrhosis

2. PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis

3. NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study

4. Pharmacological and Clinical Aspects of Heme Oxygenase

5. Heme Oxygenase Gene Targeting to Adipocytes Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction Note: PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats;International Journal of Obesity;2024-07-16

2. Studying the Role of Heme Oxygenase-1 in Obese Patients;Baghdad Science Journal;2023-12-24

3. An Assessment of Heme Oxygenase-1 and Glutathione-S-transferase in Obese Iraqi Patients;Baghdad Science Journal;2023-11-19

4. Retraction;Obesity;2023-02-27

5. Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease;Biomolecules;2023-01-29